Drug delivery market to reach $1.6bn
New drug delivery systems to enter healthcare over the next decade.
Read more hereNew vaccine delivery technologies for better immune response
Clinical trials show delivery of vaccines via new techniques induces greater immune responses than traditional methods.
Secure your placeSamsung Biologics and AstraZeneca expand partnership
Samsung Biologics expanded its biopharmaceutical manufacturing collaboration with AstraZeneca based on a long-term strategic deal.
View the latest programPast Attendees
- Human Metabolome Technologies
- Biomillenia
- Seventure Partners
- University of Jyväskylä
- Symbiome
- Evonik Corporation
- Concerto Biosciences
- MaMome Inc.
- Roche
- Biomillenia
- University of Manchester
- BDD Pharma
- University College Cork
- University of British Columbia
- Thorne HealthTech
- Seventure Partners
- Bayer
Who should attend
- Drug Development
- Drug Manufacturing
- Business Development
- Drug Delivery Systems
- Drug Formulation
- Clinical Trials and Approvals
- Drug Discovery
- Clinical Trials
- Manufacturing Research & Innovation
- Biotherapeutics & Biologics
- Clinical Diagnostics
- Research and Development
- Biotechnology Research
- Companion Diagnostics
- Strategy, Projects, & Public Affairs
- Nanotechnologies
- Theragnostic
- Sales and Marketing Initiatives
- Nano & Micro Robotics
- System Biology and Research
- Legal and Regulatory
- Modalities Research
- Precision Medicine
- Equipment Certification Services
- Molecular Medicine
- Laboratory Equipment
- News Reporting and Journalism
- Biotechnology Companies
- Biosimilars Companies
- Associations and Alliances
- Pharmaceutical Companies
- Generic Drugs Companies
- Universities and Academia
- Biosimilar Industries
- Medical Technology Companies
- Research and Development
- Biologics Industries
- Cosmetic Companies
- Government Agencies
- Drug Development Companies
- Clinical Research Organizations
- Consultants and Advisors
- Drug Discovery Companies
- Biological Engineering Companies
- Public Consultation Groups
- Formulation Companies
- Global Healthcare Institutions
- Legal and Compliance Services
- Pharma Manufacturing Companies
- International Quality Standards
- News Reporters and Journalists
Expert Speakers to Date
- Robert Thompson
University of Colorado Boulder - Tsute Chen
The Forsyth Institute - Satu Pekkala
University of Jyväskylä - Larry Weiss
Symbiome - Kamlesh Oza
Evonik Corporation - Cheri Ackerman
Concerto Biosciences - Nini Fan
MaMome Inc. - Alex Dajkovic
Biomillenia - Aline Miller
University of Manchester - Fiona MacDougall
BDD Pharma Ltd
Why Attend
The Drug Delivery Summit 2024 is the only event of its kind to deliver leading market intelligence and industry presentations on the latest in drug delivery technologies and formulations for better deliverability of drugs to target diseases…
view more...Subscribe for updates:
Exclusive Forum for Drug Delivery Technologies and Formulation
Welcome to the Drug Delivery Summit 2024, where global pharmaceutical and nanotechnology companies will meet with leading experts and researchers in Los Angeles, California, to explore the latest drug delivery technologies and optimized formulations.
Global leaders are fast developing a wide range of new drug delivery technologies, including inhalation devices and combination products to deliver new vaccines and antiviral drugs, RNA drug delivery, and novel strategies for developing new drug modalities and biotherapeutics.
Extraordinary progress has been made in drug delivery, such as localized and targeted delivery; however, the next phase will adopt new technologies to help overcome the challenges in formulation development and explore new pathways that will better enable drug absorption and biodistribution to target disease sites.
This year’s Drug Delivery Summit 2024 event is set to become the world’s leading exhibition and conference exclusively for pharmaceutical and nanotechnology companies to address scientific and business solutions in drug delivery strategies across various therapeutic platforms, with a unique emphasis on emerging technologies and to prepare for the future of clinical care.
Key topics on this year’s agenda include:
- Formulation design for poorly soluble compounds
- New drug delivery technologies for better deliverability
- Latest developments in controlled released technologies
- Optimizing drug formulations for continuous manufacturing
- Overcoming the blood-brain barrier and re-engineering biologics
- Developing new drug modalities and biotherapeutics
This event will provide a forum for all stakeholders across the global pharmaceutical and nanotechnology industries to network and build cross-market relationships to explore new technologies and technical know-how to address drug delivery and formulation challenges.
Call for Presentation
If you would like to be a speaker at this event, please get in touch with sean.collins@iQ-Hub.com, subject heading “Call for Papers - Drug Delivery Summit 2024”
To secure your place at the Drug Delivery Summit 2024 or if you require more information, please get in touch with delegates@iQ-Hub.com.
Key topics for 2024:
- Formulation design for poorly soluble compounds
Understand the most recent technological advancements to improve the dissolution and bioavailability of poorly soluble drugs. - New drug delivery technologies for better deliverability
The future of drug deliveries across the skin barrier to the systemic circulation via Iontophoresis, electroporation, sonophoresis, magnetophoresis, dermal patches, nanocarriers, and needled and needle-less shots. - Latest developments in controlled released technologies
Evaluate controlled release methods that enhance drug therapy's safety, efficacy, reliability, and convenience by controlling the rate and duration of drug release to control drug actions. - Optimizing drug formulations for continuous manufacturing
Learn about new methods in continuous pharmaceutical manufacturing for the pharmaceutical industry, which offers the potential for cost reduction, enhanced efficiency, and economic viability. - Overcoming the blood-brain barrier and re-engineering biologics
Looking at the structural elements and anatomical features of the blood-brain barrier, various in vivo, in situ blood-brain barrier models, and adopting molecular Trojan horse technologies. - Developing new drug modalities and biotherapeutics
Achieve a deeper understanding of biotherapeutics and novel drug modalities beyond traditional small molecules, including RNA-based approaches, targeted protein degradation, covalent inhibitors, next-generation peptides, and antibodies.
Testimonials
- Highly informational event with lots of opportunities to engage with other people from the field
Ying Wang (Johnson & Johnson) - Excellent speakers line up. Showcasing the science and results from across the industry
Anne Renton (Merck) - Well organized and great discussions. Networking opportunities were excellent
Carolyn Dulney (Roche) - Provided a great learning opportunity and served as a very good networking event
Mike Zimmer (Novartis) - I loved the show! Very informative conference and a great group of people
Wensheng Du (GlaxoSmithKline) - Excellent conference. Very useful information. Well organized event and agenda was very appropriate
Barry Rosen (Sanofi)
